Literature DB >> 8317503

Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.

M Tassabehji1, T Strachan, M Sharland, A Colley, D Donnai, R Harris, N Thakker.   

Abstract

Type 1 neurofibromatosis (NF1), Watson syndrome (WS), and Noonan syndrome (NS) show some overlap in clinical manifestations. In addition, WS has been shown to be linked to markers flanking the NF1 locus and a deletion at the NF1 locus demonstrated in a WS patient. This suggests either that WS and NF1 are allelic or that phenotypes arise from mutations in very closely linked genes. Here we provide evidence for the former by demonstrating a mutation in the NF1 gene in a family with features of both WS and NS. The mutation is an almost perfect in-frame tandem duplication of 42 bases in exon 28 of the NF1 gene. Unlike the mutations previously described in classical NF1, which show a preponderance of null alleles, the mutation in this family would be expected to result in a mutant neurofibromin product.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317503      PMCID: PMC1682238     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Noonan phenotype associated with neurofibromatosis.

Authors:  J E Allanson; J G Hall; M I Van Allen
Journal:  Am J Med Genet       Date:  1985-07

2.  The neurofibromatosis-Noonan syndrome.

Authors:  J M Opitz; D D Weaver
Journal:  Am J Med Genet       Date:  1985-07

Review 3.  Noonan syndrome.

Authors:  J E Allanson
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

5.  Pulmonary stenosis, café-au-lait spots, and dull intelligence.

Authors:  G H Watson
Journal:  Arch Dis Child       Date:  1967-06       Impact factor: 3.791

6.  Physical mapping of a translocation breakpoint in neurofibromatosis.

Authors:  J W Fountain; M R Wallace; M A Bruce; B R Seizinger; A G Menon; J F Gusella; V V Michels; M A Schmidt; G W Dewald; F S Collins
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

7.  Vertical transmission of the neurofibromatosis/Noonan syndrome.

Authors:  T Quattrin; E McPherson; T Putnam
Journal:  Am J Med Genet       Date:  1987-03

8.  Neurofibromatosis with fully expressed Noonan syndrome.

Authors:  D N Abuelo; D L Meryash
Journal:  Am J Med Genet       Date:  1988-04

9.  Analysis of mutations at the neurofibromatosis 1 (NF1) locus.

Authors:  M Upadhyaya; M Shen; A Cherryson; J Farnham; J Maynard; S M Huson; P S Harper
Journal:  Hum Mol Genet       Date:  1992-12       Impact factor: 6.150

10.  Precise localization of NF1 to 17q11.2 by balanced translocation.

Authors:  D H Ledbetter; D C Rich; P O'Connell; M Leppert; J C Carey
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

View more
  20 in total

1.  Characterization of Saccharomyces cerevisiae strains expressing ira1 mutant alleles modeled after disease-causing mutations in NF1.

Authors:  R Gil; J M Seeling
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.

Authors:  Igor D'Angelo; Stefan Welti; Fabien Bonneau; Klaus Scheffzek
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

Review 3.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

4.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.

Authors:  K S Au; J A Rodriguez; J L Finch; K A Volcik; E S Roach; M R Delgado; E Rodriguez; H Northrup
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome.

Authors:  C J van Asperen; W C Overweg-Plandsoen; M H Cnossen; D A van Tijn; R C Hennekam
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

6.  SPRED 1 mutations in a neurofibromatosis clinic.

Authors:  Talia M Muram-Zborovski; David A Stevenson; David H Viskochil; David C Dries; Andrew R Wilson
Journal:  J Child Neurol       Date:  2010-02-22       Impact factor: 1.987

7.  Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene.

Authors:  E Legius; R Wu; M Eyssen; P Marynen; J P Fryns; J J Cassiman
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

8.  Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation.

Authors:  Shay Ben-Shachar; Shlomi Constantini; Hen Hallevi; Emma K Sach; Meena Upadhyaya; Gareth D Evans; Susan M Huson
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

9.  Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.

Authors:  D A Stevenson; D H Viskochil; A F Rope; J C Carey
Journal:  Clin Genet       Date:  2006-03       Impact factor: 4.438

10.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.